Medical devices, healthcare technology and the business of care
510(k) clearance · K261736

MAGENTA BLAST

Future Fertility, Inc. · Decision date Sep 18, 2026

MEDTECHLEDGER EXPLANATIONK261736

What did the FDA decide?

FDA recorded a substantially equivalent (SESE) decision for MAGENTA BLAST, a traditional 510(k) submitted by Future Fertility, Inc. of Toronto, Canada, under number K261736. The decision date is 2026-09-18 and the application was received 05/27/2026. The device falls under classification name Embryo Image Assessment System, Assisted Reproduction, regulation number 884.6195, product code PBH, with the review panel and medical specialty listed as Obstetrics/Gynecology. SESE means the device was cleared as substantially equivalent to a predicate; it is not a PMA approval.

The public record lists a clinical trial identifier, NCT07464275, and states the submission was not reviewed by a third party, is not a combination product, and has no authorized predetermined change control plan. The specific components, software functions or changed items covered by the clearance are not described in the available source, and no summary statement is present, so the scope of what was cleared beyond the classification and product code remains unknown.

No clinical performance, efficacy or patient-selection conclusions are drawn here; those details would reside in the original FDA documents rather than this database entry.

Regulatory pathway
510(k) premarket notification
Clinical specialty
Obstetrics/Gynecology
Decision date
Sep 18, 2026
FDA decision documents: 510(k) Premarket Notification

FDA source record · MedtechLedger’s explanation describes the recorded change.

Regulatory record facts

Identifier
K261736
Regulatory pathway
510(k) premarket notification
Product code
PBH
Decision code
SESE
Decision date
Sep 18, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Embryo Image Assessment System, Assisted Reproduction.

Product code
PBH
FDA device class
2

FDA decision timeline

  1. K261736 received

    Application receipt date recorded by FDA.

  2. K261736 · FDA decision

    SESE

Related devices and submissions

Explore the linked device profile

No additional submissions with a verified PMA or product-code relationship are linked here.

Regulatory context

A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Future Fertility, Inc.

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
Toronto

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records